A sebum-selective 1726-nm laser treatment provides year-long control of moderate-to-severe acne across all skin types, with ...

Doctors warn that young people are turning to vaping in increasing numbers, but GPs lack the guidance, data, and tools to ...

Dr Aaron Holley explores APRV vs low tidal volume ventilation in ARDS, weighing physiologic promise against the need for ...

A new Apple Watch feature passively analyzes optical heart sensor data during waking hours to flag 'possible hypertension' ...

Nerandomilast, marketed as Jascayd by its manufacturer Boehringer Ingelheim, is the first therapy approved in more than 10 ...

Noninvasive tests show improvements in several relevant markers in patients with metabolic dysfunction-associated ...

As the fall immunization season begins, physicians are turning to multiple strategies to get shots into arms as they juggle ...

Among reproductive-aged women across nine US states, only 3% with high Desire to Avoid Pregnancy (DAP) scores became pregnant ...

Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...

EU and French regulators report no demonstrated link between prenatal paracetamol exposure and autism, and current pregnancy ...

A new approval makes Regeneron’s PD-1 blocker the only immunotherapy approved for CSCC after surgery and radiation.

A simultaneous or sequential combination of brentuximab vedotin and radiotherapy is feasible and well tolerated in patients ...